Palliative care for patients with Parkinson’s disease: an interdisciplinary review and next step model

References

• Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G. Burden of illness in Parkinson’s disease. Mov Disord. 2005;20(11):1449–1454.
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Gao W, Saleem TZ, et al. Symptoms and quality of life in late stage parkinson syndromes: a longitudinal community study of predictive factors. PLoS One. 2012;7(11):e46327.
   PubMed Web of Science ®Google Scholar
• Carter JH, Stewart BJ, Archbold PG, et al. Living with a person who has parkinson’s disease: the spouse’s perspective by stage of disease. Parkinson’s Study Group. Mov Disord. 1998;13(1):20–28.
   PubMed Web of Science ®Google Scholar
• WHO Definition of Palliative Care. Available from: http://www.who.int/cancer/palliative/definition. Accessed January 5, 2017.
   Google Scholar
• Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry. 2003;74(9):1258–1261.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Odin P, Antonini A, Martinez-Martine P. Parkinson’s disease: the non-motor issues. Parkinsonism Relat Disord. 2011;17(10):717–723.
   PubMed Web of Science ®Google Scholar
• Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008;15(1):14–20.
   PubMedGoogle Scholar
• Seppi K, Weintraub D, Coelho M, et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011;26(Suppl 3):S42–S80.
   PubMed Web of Science ®Google Scholar
• Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in parkinson’s disease: prevalence and characteristics. Pain. 2009;141(1–2):173–177.
   PubMed Web of Science ®Google Scholar
• Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of parkinson disease: Evidence from a case-control study. Arch Neurol. 2008;65(9):1191–1194.
   PubMedGoogle Scholar
• Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic parkinson’s disease. J Pain Symptom Manage. 2006;32(5):462–469.
   PubMed Web of Science ®Google Scholar
• Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord. 2010;25(11):1646–1651.
   PubMed Web of Science ®Google Scholar
• Roh JH, Kim BJ, Jang JH, et al. The relationship of pain and health-related quality of life in Korean patients with Parkinson’s disease. Acta Neurol Scand. 2009;119(6):397–403.
   PubMed Web of Science ®Google Scholar
• Goy ER, Carter J, Ganzini L. Neurologic disease at the end of life: caregiver descriptions of parkinson disease and amyotrophic lateral sclerosis. J Palliat Med. 2008;11(4):548–554.
   PubMed Web of Science ®Google Scholar
• Ford B. Pain in Parkinson’s disease. Mov Disord. 2010;25:S98–S103.
   PubMed Web of Science ®Google Scholar
• Cury RG, Galhardoni R, Fonoff ET, et al. Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology. 2014;83(16):1403–1409.
   PubMed Web of Science ®Google Scholar
• Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson’s disease: prevalence and impact on daily life. Clin Auton Res. 2005;15(2):76–82.
   PubMed Web of Science ®Google Scholar
• Pfeiffer RF. Autonomic dysfunction in Parkinson’s disease. Expert Rev Neurother. 2012;12(6):697–706.
   PubMed Web of Science ®Google Scholar
• Mostile G, Jankovic J. Treatment of dysautonomia associated with Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(Suppl 3):S224–S232.
   PubMed Web of Science ®Google Scholar
• Kabay SC, Kabay S, Yucel M, Ozden H. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. Neurourol Urodyn. 2009;28(1):62–67.
   PubMed Web of Science ®Google Scholar
• Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson’s disease and multiple system atrophy. J Urol. 2009;182(4):1453–1457.
   PubMed Web of Science ®Google Scholar
• Hyson HC, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord. 2002;17(6):1318–1320.
   PubMed Web of Science ®Google Scholar
• Friedman A, Potulska A. Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat Disord. 2001;7(4):329–332
   PubMed Web of Science ®Google Scholar
• McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson T, Fink J, Roger D. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson’s disease patients without dementia. Parkinsonism Relat Disord. 2008;14(1):37–42.
   PubMed Web of Science ®Google Scholar
• Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry. 2000;69(3):308–312.
   PubMed Web of Science ®Google Scholar
• Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–189.
   PubMed Web of Science ®Google Scholar
• Gallagher DA, Schrag A. Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Dis. 2012;46(3):581–589.
   PubMed Web of Science ®Google Scholar
• Pontone GM, Williams JR, Anderson KE, et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord. 2009;24(9):1333–1338.
   PubMed Web of Science ®Google Scholar
• Pedersen KF, Larsen JP, Alves G, Aarsland D. Prevalence and clinical correlates of apathy in Parkinson’s disease: A community-based study. Parkinsonism Relat Disord. 2009;15(4):295–299.
   PubMed Web of Science ®Google Scholar
• Fénelon G, Alves G. Epidemiology of psychosis in Parkinson’s disease. J Neurol Sci. 2010;289(1–2):12–17.
   PubMed Web of Science ®Google Scholar
• Maricle RA, Nutt JG, Valentine RJ, Carter JH. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson’s disease: a double-blind, placebo-controlled study. Neurology. 1995;45(9):1757–1760.
   PubMed Web of Science ®Google Scholar
• Menza MA, Sage J, Marshall E, Cody R, Duvoisin R. Mood changes and “on-off” phenomena in Parkinson’s disease. Mov Disord. 1990;5(2):148–151.
   PubMed Web of Science ®Google Scholar
• Barone P, Scarzella L, Marconi R, et al; Depression/Parkinson Italian Study Group. Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease. J Neurol. 2006;253(5):601–607.
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Burdick KE, Endick CJ. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry. 2004;161(3):564–566.
   PubMed Web of Science ®Google Scholar
• Richard IH, Schiffer RB, Kurlan R. Anxiety and Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1995;8(4):383–392.
   Web of Science ®Google Scholar
• Czernecki V, Schüpbach M, Yaici S, et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov. Disord. 2008;23(7):964–969.
   PubMed Web of Science ®Google Scholar
• Kuzuhara S. Drug-induced psychotic symptoms in Parkinson’s disease: problems, management and dilemma. J Neurol. 2001;248(Suppl 3):11128–11131.
   Google Scholar
• Schrag A. Psychiatric aspects of Parkinson’s disease. J Neurol. 2004;251(7):795–804.
   PubMed Web of Science ®Google Scholar
• Dobkin RD, Menza M, Allen LA, et al. Cognitive-behavioral therapy for depression in Parkinson’s disease: a randomized, controlled trial. Am J Psychiatry. 2011;168(10):1066–1074.
   PubMed Web of Science ®Google Scholar
• Cole K, Vaughan FL. The feasibility of using cognitive behaviour therapy for depression associated with Parkinson’s disease: a literature review. Parkinsonism Relat Disord. 2005;11(5):269–276.
   PubMed Web of Science ®Google Scholar
• Diederich NJ, Pieri V, Goetz CG. Coping strategies for visual hallucinations in Parkinson’s disease. Mov Disord. 2003;18(7):831–832.
   PubMed Web of Science ®Google Scholar
• Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14(8):744–748.
   PubMed Web of Science ®Google Scholar
• Oerlemans WG, de Weerd AW. The prevalence of sleep disorders in patients with Parkinson’s disease: a self-reported, community-based survey. Sleep Med. 2002;3(2):147–149.
   PubMed Web of Science ®Google Scholar
• Duncan GW, Khoo TK, Yarnall AJ, et al. Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord. 2014;29(2):195–202.
   PubMed Web of Science ®Google Scholar
• Schrempf W, Brandt MD, Storch A, Reichmann H. Sleep disorders in parkinson’s disease. J Parkinsons Dis. 2014;4(2):211–221.
   PubMedGoogle Scholar
• Friedman JH, Chou KL. Sleep and fatigue in Parkinson’s disease. Parkinsonism Relat Disord. 2004;10(Suppl 1):S27–S35.
   PubMedGoogle Scholar
• Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ. Melatonin for sleep disturbances in Parkinson’s disease. Sleep Med. 2005;6(5):459–466.
   PubMed Web of Science ®Google Scholar
• Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord. 1996;11(2):214–216.
   PubMed Web of Science ®Google Scholar
• Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4(4):281–284.
   PubMed Web of Science ®Google Scholar
• Pohar SL, Allyson Jones C. The burden of Parkinson disease (PD) and concomitant comorbidities. Arch Gerontol Geriatr. 2009;49(2):317–321.
   PubMed Web of Science ®Google Scholar
• Lubomski M, Rushworth RL, Tisch S. Hospitalisation and comorbidities in Parkinson’s disease: a large Australian retrospective study. J Neurol Neurosurg Psychiatry. 2015;86(3):324–330.
   PubMed Web of Science ®Google Scholar
• Bainbridge JL, Ruscin JM. Challenges of treatment adherence in older patients with parkinson’s disease. Drugs Aging. 2009;26(2):145–155.
   PubMed Web of Science ®Google Scholar
• Ranelli PL, Aversa SL. Medication-related stressors among family caregivers. Am J Health Syst Pharm. 1994;51(1):75–79.
   Google Scholar
• Terriff DL, Williams JV, Patten SB, Lavorato DH, Bulloch AG. Patterns of disability, care needs, and quality of life of people with Parkinson’s disease in a general population sample. Parkinsonism Relat Disord. 2012;18(7):828–832.
   PubMed Web of Science ®Google Scholar
• Hassan A, Wu S, Schmidt P, et al. What are the issues facing Parkinson’s disease patients at ten years of disease and beyond? Data from the NPF-QII study. Parkinsonism Relat Disord. 2012;18(Suppl 3):S10–S14.
   PubMedGoogle Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver’s burden in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(6):629–634.
   PubMed Web of Science ®Google Scholar
• Miyasaki J, Kluger B. Palliative care for parkinson’s disease: has the time come? Curr Neurol Neurosci Rep. 2015;15(5):26.
   PubMed Web of Science ®Google Scholar
• Greenwell K, Gray WK, van Wersch A, van Schaik P, Walker R. Predictors of the psychosocial impact of being a carer of people living with Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2015;21(1):1–11.
   PubMed Web of Science ®Google Scholar
• Lageman SK, Mickens MN, Cash TV. Caregiver-identified needs and barriers to care in Parkinson’s disease. Geriatr Nurs. 2015;36(3):197–201.
   PubMed Web of Science ®Google Scholar
• Richfield EW, Jones EJ, Alty JE. Palliative care for Parkinson’s disease: A summary of the evidence and future directions. Palliat Med 2013;27(9):805–810.
   PubMed Web of Science ®Google Scholar
• Hudson P, Payne S. Family caregivers and palliative care: current status and agenda for the future. J Palliat Med. 2010;14(7):864–869.
   Web of Science ®Google Scholar
• Oguh O, Kwasny M, Carter J, Stell B, Simuni T. Caregiver strain in Parkinson’s disease: national parkinson foundation quality initiative study. Parkinsonism Relat Disord. 2013;19(11):975–979.
   PubMed Web of Science ®Google Scholar
• Stull DE. The multidimensional caregiver strain index (MCSI): its measurement and structure. J Clin Geropsychol. 1996;2(3):175–96.
   Google Scholar
• Lyons KS, Stewart BJ, Archbold PG. Optimism, Pessimism, Mutuality, and Gender: Predicting 10-Year Role Strain in Parkinson’s Disease Spouses. Gerontologist. 2009;49(3):378–387.
   PubMed Web of Science ®Google Scholar
• Levine C. The Loneliness of the Long-Term Care Giver. N Engl J Med. 1999;340(20):1587–1590.
   PubMed Web of Science ®Google Scholar
• Lloyd J, Patterson T, Muers J. The positive aspects of caregiving in dementia: a critical review of the qualitative literature. Dementia. 2016;15(6):1534–1561.
   PubMedGoogle Scholar
• Given B, Sherwood PR, Given CW. What Knowledge and Skills do caregivers need? Am J Nurs. 2008;108(Suppl 9):28–34.
   PubMed Web of Science ®Google Scholar
• D’Amelio M, Terruso V, Palmeri B, et al. Predictors of caregiver burden in partners of patients with Parkinson’s disease. Neurol Sci. 2009;30(2):171–174.
   PubMed Web of Science ®Google Scholar
• Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006;12(1):35–41.
   PubMed Web of Science ®Google Scholar
• Hudson P, Remedios C, Zordan R, et al. Guidelines for the psychosocial and bereavement support of family caregivers of palliative care patients. J Palliat Med. 2012;15(6):696–702.
   PubMed Web of Science ®Google Scholar
• Hudson P, Aranda S. The Melbourne family support program: evidence-based strategies that prepare family caregivers for supporting palliative care patients. BMJ Support Palliat Care. 2014;4(3):231–237.
   PubMedGoogle Scholar
• Hudson P, Trauer T, Kelly B, et al. Reducing the psychological distress of family caregivers of home based palliative care patients: longer term effects from a randomised controlled trial. PsychoOncology. 2015;24(1):19–24.
   PubMed Web of Science ®Google Scholar
• Corry M, While A, Neenan K, Smith V. A systematic review of systematic reviews on interventions for caregivers of people with chronic conditions. J Adv Nurs. 2015;71(4):718–734.
   PubMed Web of Science ®Google Scholar
• Volicer L, Simard J. Palliative care and quality of life for people with dementia: medical and psychosocial interventions. Int Psychogeriatr. 2015;27(10):1623–1634.
   PubMed Web of Science ®Google Scholar
• Lorig KR, Ritter P, Stewart AL, et al. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med care. 2001;39(11):1217–1223.
   PubMed Web of Science ®Google Scholar
• Kegelmeyer DA, Parthasarathy S, Kostyk SK, White SE, Kloos AD. Assistive devices alter gait patterns in Parkinson disease: Advantages of the four-wheeled walker. Gait Posture. 2013;38(1):20–24.
   PubMed Web of Science ®Google Scholar
• Santesso N, Carrasco-Labra A, Brigardello-Peterson R. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev. 2014;(3):CD001255.
   Google Scholar
• Huang HC, Lee CH, Wu SL. Hip protectors: a pilot study of older people in Taiwan. J Clin Nurs. 2006;15(4):436–443.
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Uchiyama T, Yamanishi T, Shirai K, Hattori T. Bladder and bowel dysfunction in Parkinson’s disease. J Neural Transm. 2008;115(3):443–460.
   PubMed Web of Science ®Google Scholar
• Morris V, Wagg A. Lower urinary tract symptoms, incontinence and falls in elderly people: time for an intervention study. Int J Clin Pract. 2007;61(2):320–323.
   PubMed Web of Science ®Google Scholar
• Sakushima K, Yamazaki S, Fukuma S, et al. Influence of urinary urgency and other urinary disturbances on falls in Parkinson’s disease. J Neurol Sci. 2016;360:153–157.
   PubMed Web of Science ®Google Scholar
• Kabay S, Canbaz Kabay S, Cetiner M, et al. The clinical and urodynamic results of percutaneous posterior tibial Nnrve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s Disease. Urology. 2016;87:76–81.
   PubMed Web of Science ®Google Scholar
• Vaughan CP, Juncos JL, Burgio KL, Goode PS, Wolf RA, Johnson TM 2nd. Behavioral therapy to treat urinary incontinence in Parkinson disease. Neurology. 2011;76(19):1631–1634.
   PubMed Web of Science ®Google Scholar
• Allen NE, Moloney N, van Vliet V, Canning CG. The Rationale for Exercise in the Management of Pain in Parkinson’s Disease. J Parkinsons Dis. 2015;5(2):229–239.
   PubMedGoogle Scholar
• Ramig LO, Sapir S, Countryman S, et al. Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: a 2 year follow up. J Neurol Neurosurg Psychiatry. 2001;71(4):493–498.
   PubMed Web of Science ®Google Scholar
• Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord. 2007;22(12):1689–1707.
   PubMed Web of Science ®Google Scholar
• Litvan I, Aarsland D, Adler CH, et al. MDS task force on mild cognitive impairment in Parkinson’s disease: Critical review of PD-MCI. Mov Disord. 2011;26(10):1814–1824.
   PubMed Web of Science ®Google Scholar
• Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837–844.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Brønnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007;78(1):36–42.
   PubMed Web of Science ®Google Scholar
• Palmer AD, Newsom JT, Rook KS. How does difficulty communicating affect the social relationships of older adults? An exploration using data from a national survey. J Commun Disord. 2016;62:131–146.
   PubMed Web of Science ®Google Scholar
• Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLOS Med. 2010;7(7):e1000316.
   PubMed Web of Science ®Google Scholar
• Lokk J, Delbari A. Clinical aspects of palliative care in advanced Parkinson’s disease. BMC Palliat Care. 2012;11:20.
   PubMed Web of Science ®Google Scholar
• Mitchell SL, Kiely DK, Lipsitz LA. The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med. 1997;157(3):327–332.
   PubMedGoogle Scholar
• Risk JL. Building a new life: a chaplain’s theory based case study of chronic illness. J Health Care Chaplain. 2013;19(3):81–98.
   PubMedGoogle Scholar
• Bingham V, Habermann B. The influence of spirituality on family management of Parkinson’s disease. J Neurosci Nurs. 2006;38(6):422–427.
   PubMedGoogle Scholar
• Gottman JM, Krokoff LJ. Marital interaction and satisfaction: A longitudinal view. J Consult Clin Psychol. 1989;57(1):47–52.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick Lee, Simpson J, Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson’s disease. Psychol Psychother. 2010;83(Pt 2):179–192.
   PubMed Web of Science ®Google Scholar
• Fishbane MD. Wired to connect: neuroscience, relationships, and therapy. Fam Process. 2007;46(3):395–412.
   PubMed Web of Science ®Google Scholar
• Gallagher DA, Schrag A. Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Dis. 2012;46(3):581–589.
   PubMed Web of Science ®Google Scholar
• Artigas NR, Striebel VL, Hilbig A, et al. Evaluation of quality of life and psychological aspects of Parkinson’s disease patients who participate in a support group. Dement Neuropsychol. 2015;9(3):295–300.
   PubMedGoogle Scholar
• Johnston M, Chu E. Does attendance at a multidisciplinary outpatient rehabilitation program for people with Parkinson’s disease produce quantitative short term or long term improvements? A systematic review. NeuroRehabilitation. 2010;26(4):375–383.
   PubMed Web of Science ®Google Scholar
• van der Marck MA, Munneke M, Mulleners W, et al; IMPACT Study Group. Integrated multidisciplinary care in Parkinson’s disease: a non-randomised, controlled trial (IMPACT). Lancet Neurol. 2013;12(10):947–956.
   PubMed Web of Science ®Google Scholar